3M Drug Delivery Systems Designs An "Intelligent Inhaler" System For COPD, Asthma And Other Respiratory Ills
According to the World Health Organization, about 334 million individuals globally are afflicted with asthma, and 65 million suffer from moderate to severe chronic obstructive pulmonary disease (COPD) — a number expected to rise 24 percent by 2034, making COPD the world’s third leading cause of death.
To meet this challenge, 3M Drug Delivery Systems is developing the “3M Intelligent Control Inhaler”, described as an intuitive, fully integrated device designed to deliver accurate doses of medication to patients, while offering on-screen instructions about the inhaler’s use, as well as feedback to the patient and healthcare provider via a mobile device app.
To meet this challenge, 3M Drug Delivery Systems is developing the “3M Intelligent Control Inhaler”, described as an intuitive, fully integrated device designed to deliver accurate doses of medication to patients, while offering on-screen instructions about the inhaler’s use, as well as feedback to the patient and healthcare provider via a mobile device app.